Amgen shareholders re-elect all 12 directors; independent-chair proposal fails

At its virtual 2026 annual meeting on May 19, Amgen shareholders elected all 12 director nominees, including Chairman and CEO Robert Bradway. The advisory say-on-pay vote passed with more than 96% of votes cast in favor. A stockholder proposal to require an independent board chairman failed, with less than 18% of votes cast in favor.

• All 12 director nominees elected, each by a majority of votes cast For
• Say-on-pay advisory vote received more than 96% For
• Ernst & Young LLP ratified as auditor with more than 93% For
• Independent board chairman proposal received less than 18% For and failed